We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Elective Angioplasty Patients Fare Equally Well in Hospitals Without Heart Surgery Capabilities

By HospiMedica International staff writers
Posted on 14 Dec 2011
Patients who had nonemergency angioplasty or stent implantation at experienced hospitals without on-site heart surgery capabilities fared no worse than those in surgery-equipped hospitals, according to a new study.

Researchers at Johns Hopkins Medical Institutions (Baltimore, MD, USA) randomly assigned 13,995 patients participating in the Cardiovascular Patient Outcomes Research Team (CPORT) study to have their percutaneous coronary intervention (PCI) done at a hospital with cardiac surgery capabilities, and 4,523 patients at hospitals without; if emergency surgery was required at a hospital without on-site surgery, the patient was transferred urgently. More...
The 60 hospitals selected without cardiac surgery capabilities had to be able to perform annually at least 200 PCIs, and the physicians doing the procedures were required to be performing more than 75 PCI cases annually.

The results showed that the mortality rate after six weeks was almost the same for each group, at less than one percent. Furthermore, emergency surgery was only needed for 20 of the 13,995 patients undergoing procedures at hospitals without on-site surgery and 10 of the 4,523 patients treated at hospitals where surgery was available. The study was presented at the American Heart Association (AHA) Scientific Sessions, held during November 2011 in Orlando (FL, USA).

“In the 1980s, the need for cardiac surgery was high; 5% to 7% of these cases could require emergency open heart or bypass surgery. The cardiac operating room was kept open in the event a complication requiring surgery occurred,” said lead author interventional cardiologist Thomas Aversano, MD. “Now it's 1 in 500 or 1 in 1,000; it's very uncommon.”

“We do not support the spread of angioplasty to every hospital in the United States. However, it can be burdensome and costly for all medical centers to have cardiac surgery capabilities,” added Dr. Aversano. “Regional healthcare planners can use the data from the study to make informed decisions about which hospitals should have PCI capability, with the aim of improving quality, improving access, and lowering costs.”

Related Links:

Johns Hopkins Medical Institutions




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.